A detailed history of Td Asset Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 243,534 shares of RVMD stock, worth $10.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
243,534
Previous 250,194 2.66%
Holding current value
$10.5 Million
Previous $9.71 Million 13.64%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$36.92 - $47.94 $245,887 - $319,280
-6,660 Reduced 2.66%
243,534 $11 Million
Q2 2024

Aug 02, 2024

SELL
$30.14 - $40.68 $132,616 - $178,992
-4,400 Reduced 1.73%
250,194 $9.71 Million
Q1 2024

May 08, 2024

SELL
$26.56 - $33.55 $455,928 - $575,919
-17,166 Reduced 6.32%
254,594 $8.21 Million
Q4 2023

Feb 12, 2024

SELL
$18.35 - $34.12 $1,174 - $2,183
-64 Reduced 0.02%
271,760 $7.79 Million
Q3 2023

Oct 27, 2023

BUY
$25.17 - $35.05 $3.52 Million - $4.91 Million
140,012 Added 106.22%
271,824 $7.52 Million
Q2 2023

Aug 09, 2023

SELL
$20.28 - $27.0 $54,756 - $72,900
-2,700 Reduced 2.01%
131,812 $3.53 Million
Q1 2023

May 10, 2023

BUY
$20.76 - $30.09 $837,437 - $1.21 Million
40,339 Added 42.83%
134,512 $2.91 Million
Q3 2022

Nov 07, 2022

BUY
$17.46 - $26.0 $242,274 - $360,776
13,876 Added 17.28%
94,173 $1.84 Million
Q2 2022

Aug 04, 2022

SELL
$14.54 - $27.17 $117,817 - $220,158
-8,103 Reduced 9.17%
80,297 $1.57 Million
Q1 2022

May 10, 2022

BUY
$17.31 - $26.4 $266,574 - $406,560
15,400 Added 21.1%
88,400 $2.26 Million
Q3 2021

Nov 09, 2021

BUY
$23.95 - $33.41 $1.07 Million - $1.49 Million
44,600 Added 157.04%
73,000 $2.01 Million
Q2 2021

Aug 11, 2021

BUY
$29.0 - $47.44 $823,600 - $1.35 Million
28,400 New
28,400 $813,000
Q3 2020

Nov 10, 2020

SELL
$22.61 - $34.8 $211,855 - $326,076
-9,370 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$20.0 - $34.08 $187,400 - $319,329
9,370 New
9,370 $205,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.